MAPK8 and asthma: TGF-β1 stimulates JNK, which phosphorylates its substrate Jun, at serine residues 63 and 73.136–139 On the other hand, silencing Gal-7 suppresses JNK activation and ameliorates bronchial epithelial cell injury, presenting a potential target for treating asthma.